about
Reporter-Expressing, Replicating-Competent Recombinant ArenavirusesAnalysis of Lujo virus cell entry using pseudotype vesicular stomatitis virus.Isolation, identification, and characterization of novel arenaviruses, the etiological agents of boid inclusion body disease.Replication of boid inclusion body disease-associated arenaviruses is temperature sensitive in both boid and mammalian cellsMolecular Basis for Antibody-Mediated Neutralization of New World Hemorrhagic Fever Mammarenaviruses.Glycoprotein-Specific Antibodies Produced by DNA Vaccination Protect Guinea Pigs from Lethal Argentine and Venezuelan Hemorrhagic Fever.A Novel Live Pichinde Virus-Based Vaccine Vector Induces Enhanced Humoral and Cellular Immunity after a Booster Dose.Role of DC-SIGN in Lassa virus entry into human dendritic cells25-Hydroxycholesterol Inhibition of Lassa Virus Infection through Aberrant GP1 Glycosylation.Reverse Genetics Approaches to Control Arenavirus.Absence of an N-Linked Glycosylation Motif in the Glycoprotein of the Live-Attenuated Argentine Hemorrhagic Fever Vaccine, Candid #1, Results in Its Improper Processing, and Reduced Surface Expression.Convergent immunological solutions to Argentine hemorrhagic fever virus neutralization.Characterization of the Glycoprotein Stable Signal Peptide in Mediating Pichinde Virus Replication and Virulence.Role of LAMP1 Binding and pH Sensing by the Spike Complex of Lassa Virus.Identification and characterization of a proteolytically primed form of the murine coronavirus spike proteins after fusion with the target cell.Molecular Mechanism for LAMP1 Recognition by Lassa Virus.In vitro and in vivo characterizations of pichinde viral nucleoprotein exoribonuclease functions.Mapping of the Lassa virus LAMP1 binding site reveals unique determinants not shared by other old world arenaviruses.Development of Recombinant Arenavirus-Based Vaccines.Alphavirus vector-based replicon particles expressing multivalent cross-protective Lassa virus glycoproteins.Interferons: Reprogramming the Metabolic Network against Viral Infection.Antibodies to the Glycoprotein GP2 Subunit Cross-React between Old and New World Arenaviruses.Vaccine-elicited receptor-binding site antibodies neutralize two New World hemorrhagic fever arenaviruses.
P2860
Q26742028-F0A6F106-4C17-4933-BCD1-D46422327047Q33744103-FCD09746-2D0F-405F-9232-CD2188DC69D0Q34362647-37EA67CF-D086-40FC-BA34-D01F9BE5A7B7Q35402001-C4CF61D3-711E-4F82-9D0A-3BEBFF6BF021Q36387971-FF0544A1-6C3F-47C0-82F2-BF8E064F9C99Q36694022-37C666B9-08D5-474C-AC40-D0F108E054FAQ36736786-0B57C3E2-C914-4979-9080-24D4A95EC76AQ37252717-916DBE75-52D4-4B5C-92B6-3CE71A848FDAQ37530422-6CB818AA-3ED2-4632-B8AD-CA7B12528F7BQ37543755-D3480FE2-17A5-43A1-8CBF-A6DAE297671CQ38715575-0335A791-FD3A-4C51-8E13-8FDEAD555FE8Q38718346-BBCB2C06-9BC7-4C34-9AE9-49976C3E57DFQ38736087-F762F7B4-05BB-41BF-9770-D5445318559AQ38736122-4C8A3F48-B6B3-4F18-9816-AB5E482A24E3Q38860071-28260FB1-A204-4B7B-A8A5-F391F6071098Q38875186-94138F6B-1DDB-49EC-83A1-780EE08D5E96Q38886677-7ACE8C86-98CE-4F40-9581-AB97DD0ADD61Q40059403-9AA0D8C4-DC38-45D0-8163-8D5DF05E595EQ40259618-CFCAF95B-F92B-4D00-A0D4-1C686EA077FDQ47244680-F25051AA-625F-4782-B799-8AC4C970A83BQ47552406-844921BE-7157-47DB-BF76-D09686420C04Q55306089-993F8AE6-F099-45C8-9705-B8E680EB0F2BQ55434508-B29295FA-6E0E-423B-993F-4E6D5BD70718
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Envelope glycoprotein of arenaviruses
@ast
Envelope glycoprotein of arenaviruses
@en
Envelope glycoprotein of arenaviruses
@nl
type
label
Envelope glycoprotein of arenaviruses
@ast
Envelope glycoprotein of arenaviruses
@en
Envelope glycoprotein of arenaviruses
@nl
prefLabel
Envelope glycoprotein of arenaviruses
@ast
Envelope glycoprotein of arenaviruses
@en
Envelope glycoprotein of arenaviruses
@nl
P2860
P921
P3181
P356
P1433
P1476
Envelope glycoprotein of arenaviruses
@en
P2093
Dominique J Burri
Joel Ramos da Palma
P2860
P304
P3181
P356
10.3390/V4102162
P407
P577
2012-10-01T00:00:00Z
2012-10-17T00:00:00Z